Pharmacy News

Subscribe to Pharmacy News feed
PharmaTimes - The latest news in healthcare and life sciences - News RSS
Updated: 3 hours 58 min ago

Bird flu outbreak confirmed in Suffolk

4 hours 43 min ago
Officials have confirmed an outbreak of bird flu in Suffolk, but stress the risk to the public is low

More good news for Janssen’s Darzalex

5 hours 5 min ago
The drug has hit survival and disease progression targets in Phase III trials

EU expands scope of Vertex’ Kalydeco

5 hours 52 min ago
Children with cystic fibrosis as young as six months with certain mutations can now access the treatment

EXCLUSIVE: Brits back sharing DNA for research

6 hours 7 sec ago
The main reason for not sharing DNA for drug research is the fear it could be used without knowledge for corporate gain

SMC green light for rare blood cancer treatment

NHS funding was backed for four medicines

Private clinic launches UK’s first MRIdian radiotherapy machine

NHS patients will be able to access the treatment via clinical trials

Healx, Boehringer link for rare neurological disease therapy

The project will utilise Healx' AI-based drug discovery platform

RCEM’s winter data reveals much worse picture of A&E waits

"We are clearly in the worst state we’ve ever been in as we enter the true winter season", says College president Dr Katherine Henderson.

Sanofi bulks up cancer offering with Synthorx buy

The French drugmaker is spending around $2.5 billion on the deal

AZ’ Calquence boosts PFS in CLL patients

The drug demonstrates “remarkable efficacy”, says AZ’ José Baselga

Survey reveals ‘critical deficiencies’ in NHS record-keeping

Policymakers must identify fragmented systems and promote better data sharing, study authours say

CAR-T therapies shine at ASH

Janssen's JNJ-4528 and BMS/bluebird bio's liso-cel show 100% response rates

Astellas, Audentes pen $3bn gene therapy deal

Genetic regulation is set to become a fifth primary focus for the Japanese drugmaker, on top of its already existing business lines.

Novartis, Amazon ink deal for ‘smart’ manufacturing

The online retail giant's honed data abilities will help Novartis produce more personalised therapies.

ViiV Healthcare submits HIV drug fostemsavir in the US

The treatment could offer a new option for patients unable to reach viral supression

PharmaTimes unveils winners of MSEA 2019

This year's competition welcomed a fantastic spread of companies as well as a higher number of entrants

INTCR 2020 Executive Steering Group Chair shares insight into this ever-growing competition

Flying the flag for clinical research for over 20 years, this competition continues to grow and develop year after year.

Late-stage Ibsrela success for Ardelyx

If approved, the drug will be the only non-binder treatment for the control of serum phosphorus in patients with CKD on dialysis.

EMA to review Amarin’s Vascepa filing

The fish oil-derived therapy is already approved in the US for patients with severe hypertriglyceridaemia.

Veeva announces updates for 2020

The system gives users “greater flexibility” to customise the company's established CRM.